WinstonWınston
Green Rain Energy Holdings logo

Green Rain Energy Holdings

GREH
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.01
-0.00 (-1.76%)
Market Cap
$107,918
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+97.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 1.56B (2021) → 3.08B (2025)

Green Rain Energy Holdings Inc. is a small healthcare company operating in the specialty and generic drug manufacturing space. It focuses on developing and distributing pharmaceutical products, targeting patients and healthcare providers who need affordable medication options. The generic drug industry is highly competitive, with many companies racing to produce lower-cost versions of brand-name medicines after patents expire.

The company generates revenue by selling pharmaceutical products, though its current financials show essentially no gross profit and a negative return on invested capital, suggesting it is in an early or transitional stage of operations. It appears to operate on a limited scale, with a market cap too small to register meaningfully. The biggest risk facing Green Rain Energy Holdings is its ability to reach sustainable revenue and profitability, as companies at this stage often struggle to compete against larger, established generic drug manufacturers with greater resources and regulatory experience.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
N/A
Data not available
Operating Margin
N/A
Data not available
ROCE
-3.2%
Weak — -3.2% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.3x
Attractive valuation — P/E 0.3

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial